I’ve been coming back to the way we talk about “closing the gap” between research and commercialization, and I’m not sure that framing really holds up anymore. We aren’t closing anything. If anything, we’re building bridges across it, and that bridge is getting longer.
There’s more translational research activity than we’ve seen before, and it’s getting more complex and more expensive. More of the earliest stages of startup formation and funding are being pulled upstream into the institution. In response, we’ve seen a steady expansion of gap fund and accelerator programs (GAP), but not as a single solution.
What’s actually emerging is a set of interdependent models working together: translational research and pre-POC programs that shape and expand the pipeline, proof-of-concept programs that focus on validation, risk reduction, and opportunity development, startup accelerators that support venture formation, and institution-affiliated venture funds that provide early investment once those thresholds are met.
As a system, GAP looks like it’s moving in the right direction, but not as a set of standalone programs. At its best, it operates as a coordinated system.
And even after all of that, most technologies coming out of research environments still aren’t ready or positioned for the increasingly diverse set of external partners and sources of support.
What the Mind the GAP work continues to reinforce is that this isn’t a temporary inefficiency. It has been the reality and likely will continue to be. It’s a structural feature of how the system operates. Research produces early signals, sometimes very strong ones, but still early. Markets require something much more developed, something that has been tested, shaped, and positioned in a way that reduces uncertainty.
Addressing that space in between is where GAP operates. This is the layer of development between those two points that doesn’t naturally get picked up by either side.
But it’s not just a buffer.
At its best, this layer creates a bridge that works in both directions. It’s where research is shaped into something the market can engage with, but it’s also where market signals, partners, and expectations are pulled upstream earlier in the process. Opportunity identification and shaping, access to operators and domain expertise, structured commercialization support, and points of interaction like pilot programs, partnerships, and investment processes all start to converge here.
Those interactions don’t happen without a bridge.
Across many of the gap fund and accelerator programs we work with, there’s been a gradual shift in response, resources, and strategy. What used to be smaller, more isolated efforts are starting to look like coordinated systems, connecting proof-of-concept, startup accelerators, and venture funding into something more continuous.
Not because it’s ideal, but because it’s necessary.
That shift reflects a different assumption about what these programs are actually doing. If the gap is temporary, you design to move things through it as efficiently as possible. If it’s structural, you design to consistently do the work that neither research nor traditional capital or markets are set up to do on their own.
More and more, it looks like the second is closer to reality.
If that’s true, then the conversation starts to change. It becomes less about whether the gap exists, and more about who is actually doing the work inside it, whether those efforts are being properly resourced and supported, and how we think about the role they play in the broader system.
Explore the full Mind the GAP 2025 Report:
Keywords: research institutions, gap fund and accelerator programs, translational research, proof-of-concept, startup accelerators, venture formation, university venture funds
